SR Cummings, DM Black, DE Thompson, WB … - Jama, 1998 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context.— Alendronate ... Cited by 1094 - Related articles - BL Direct - All 5 versions
- ►washington.edu [PDF] PD Delmas - The Lancet, 2002 - Elsevier The aim of treatment of postmenopausal osteoporosis is to reduce the frequency
of vertebral and non-vertebral fractures (especially at the hip), which are
responsible for morbidity associated with the disease. Results of large ... Cited by 361 - Related articles - All 9 versions
SR Cummings, DM Black, DE Thompson, WB … - Jama, 1998 - Am Med Assoc Steven R. Cummings, MD; Dennis M. Black, PhD; Desmond E. Thompson, PhD; William
B. Applegate, MD; Elizabeth Barrett-Connor, MD; Thomas A. Musliner, MD; Lisa
Palermo, MA; Ronald Prineas, MD; Susan M. Rubin, MA; Jean C. Scott, PhD; ... Cited by 259 - Related articles - View as HTML
A Cranney, G Wells, A Willan, L Griffith, N … - Endocrine reviews, 2002 - Endocrine Soc Data Source: We searched MEDLINE, EMBASE, Current Contents, and the Cochrane
Controlled trials registry from 1980 to 1999, and we examined citations of
relevant articles and proceedings of international meetings. Cited by 237 - Related articles - BL Direct - All 7 versions
R Lindsay, F Cosman, RA Lobo, BW Walsh, ST … - Climacteric, 1999 - informahealthcare.com Hormone replacement therapy: patterns of use studied through British general
practice computerized records ... M. Lawrence, L. ]ones, T. Lancaster, E. Duly
and E. Banks Fam Pract 1999; 16:335-42 ... Objective We aimed to describe ... Cited by 203 - Related articles - BL Direct - All 7 versions
HD Nelson, M Helfand, SH Woolf, JD Allan - Annals of Internal Medicine, 2002 - Am Coll Physicians Background: Although osteoporotic fractures present an enormous health burden,
it is not clear whether screening to identify high-risk persons is appropriate. ... Purpose: To examine evidence on the benefits and harms of screening ... Cited by 201 - Related articles - All 13 versions
- Free from Publisher JC Prior - Endocrine Reviews, 1998 - saegre.org.ar MENOPAUSE, and especially the years late after it, are currently understood to
carry significant risks for heart disease and osteoporosis (1, 2). These health
consequences of the late postmenopause are believed to be caused by low ... Cited by 170 - Related articles - View as HTML - BL Direct - All 6 versions
PJ Meunier, PD Delmas, R Eastell, MR … - Clinical therapeutics, 1999 - Elsevier The authors, all physicians involved in clinical research on bone and practicing
clinicians, propose practical guidelines for identifying persons with
osteoporosis or those at high risk of developing the disease and for ... Cited by 164 - Related articles - BL Direct - All 5 versions
- ►drexelmed.edu [PDF] P Roschger, S Rinnerthaler, J Yates, GA Rodan … - Bone, 2001 - Elsevier The strength of bone is correlated with bone mass but is also influenced
significantly by other factors such as structural properties of the matrix (eg,
collagen mutations) and the mineral. Changes at all levels of this ... Cited by 160 - Related articles - BL Direct - All 11 versions
- ►endojournals.org I Fogelman, C Ribot, R Smith, D Ethgen, E … - Journal of Clinical Endocrinology & Metabolism, 2000 - Endocrine Soc At 24 months, lumbar spine BMD increased from baseline by 4% with 5 mg
risedronate and 1.4% in the 2.5-mg group, compared with no change with placebo.
Efficacy was similar in women who were less than 5 yr and more than 5 yr ... Cited by 142 - Related articles - BL Direct - All 7 versions
